Rolipram is a selective phosphodiesterase-4 inhibitor discovered and developed by Schering AG as a potential antidepressant drug in the early 1990s.
Rolipram, a medication designed to inhibit phosphodiesterase-4, was created by Schering AG with the goal of treating depression in the early 1990s.